<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40656785</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2223-3652</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Cardiovascular diagnosis and therapy</Title><ISOAbbreviation>Cardiovasc Diagn Ther</ISOAbbreviation></Journal><ArticleTitle>Role of annexin A7 in the occurrence and progression of coronary atherosclerosis: a narrative review.</ArticleTitle><Pagination><StartPage>653</StartPage><EndPage>664</EndPage><MedlinePgn>653-664</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/cdt-24-544</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="UNASSIGNED">Cardiovascular diseases, particularly coronary atherosclerosis, pose a major health burden, with plaque rupture and erosion contributing to acute coronary syndrome (ACS). Platelet adhesion and aggregation are key in thrombosis, making them critical therapeutic targets. This study aimed to elucidate the regulatory role of annexin A7 (ANXA7) in the progression of coronary atherosclerosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A literature review was performed using PubMed and Google Scholar. Clinical trials, meta-analyses, randomized controlled trials, reviews, and systematic reviews were considered. Articles published in languages other than English with limited text availability were excluded.</AbstractText><AbstractText Label="KEY CONTENT AND FINDINGS" NlmCategory="UNASSIGNED">ANXA7 plays a crucial role in coronary atherosclerosis by regulating endothelial stability, inflammatory metabolism, and Ca<sup>2+</sup> mobilization, which influences platelet activation and lipid metabolism. Its potential to prevent thrombosis without impairing hemostasis may offer a breakthrough in platelet therapy for coronary artery disease (CAD).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">As a multifunctional regulatory factor, ANXA7 participates in coronary atherosclerosis progression through calcium signaling modulation and inflammatory metabolic regulation, with its unique "antithrombotic without compromising hemostasis" property holding promise to overcome current therapeutic limitations in CAD. Further investigation into the role of ANXA7 in coronary atherosclerosis is crucial for elucidating its pathogenic mechanisms and exploring potential clinical applications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 AME Publishing Company. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Lifang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Lingling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hangyao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lihong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Cardiovasc Diagn Ther</MedlineTA><NlmUniqueID>101601613</NlmUniqueID><ISSNLinking>2223-3652</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Molecular</Keyword><Keyword MajorTopicYN="N">annexinA7 (ANXA7)</Keyword><Keyword MajorTopicYN="N">coronary artery atherosclerosis</Keyword><Keyword MajorTopicYN="N">lipid metabolism</Keyword><Keyword MajorTopicYN="N">platelet</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://cdt.amegroups.com/article/view/10.21037/cdt-24-544/coif). L.W. reports that this study was supported by the National Natural Science Foundation of China (No. 81670447), the Medicine and Health Project of Zhejiang Province (No. 2023KY531) and the Traditional Chinese Medicine Program of Zhejiang Province (Nos. 2022ZZ003, 2023ZL248 and 2022ZB024). The other authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40656785</ArticleId><ArticleId IdType="pmc">PMC12246990</ArticleId><ArticleId IdType="doi">10.21037/cdt-24-544</ArticleId><ArticleId IdType="pii">cdt-15-03-653</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fox KAA, Metra M, Morais J, et al. The myth of 'stable' coronary artery disease. Nat Rev Cardiol 2020;17:9-21. 10.1038/s41569-019-0233-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0233-y</ArticleId><ArticleId IdType="pubmed">31358978</ArticleId></ArticleIdList></Reference><Reference><Citation>Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun 2006;20:113-9. 10.1016/j.bbi.2005.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2005.08.002</ArticleId><ArticleId IdType="pubmed">16183245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmark BA, Mathenge N, Merlini PA, et al. Acute coronary syndromes. Lancet 2022;399:1347-58. 10.1016/S0140-6736(21)02391-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02391-6</ArticleId><ArticleId IdType="pmc">PMC8970581</ArticleId><ArticleId IdType="pubmed">35367005</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Pasterkamp G, Crea F, et al. Reassessing the Mechanisms of Acute Coronary Syndromes. Circ Res 2019;124:150-60. 10.1161/CIRCRESAHA.118.311098</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.311098</ArticleId><ArticleId IdType="pmc">PMC6447371</ArticleId><ArticleId IdType="pubmed">30605419</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002;82:331-71. 10.1152/physrev.00030.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00030.2001</ArticleId><ArticleId IdType="pubmed">11917092</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava M, Bubendorf L, Srikantan V, et al. ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci U S A 2001;98:4575-80. 10.1073/pnas.071055798</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.071055798</ArticleId><ArticleId IdType="pmc">PMC31876</ArticleId><ArticleId IdType="pubmed">11287641</ArticleId></ArticleIdList></Reference><Reference><Citation>Manke MC, Geue S, Coman C, et al. ANXA7 Regulates Platelet Lipid Metabolism and Ca(2+) Release in Arterial Thrombosis. Circ Res 2021;129:494-507. 10.1161/CIRCRESAHA.121.319207</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319207</ArticleId><ArticleId IdType="pubmed">34176316</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005;6:449-61. 10.1038/nrm1661</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1661</ArticleId><ArticleId IdType="pubmed">15928709</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns AL, Magendzo K, Shirvan A, et al. Calcium channel activity of purified human synexin and structure of the human synexin gene. Proc Natl Acad Sci U S A 1989;86:3798-802. 10.1073/pnas.86.10.3798</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.10.3798</ArticleId><ArticleId IdType="pmc">PMC287228</ArticleId><ArticleId IdType="pubmed">2542947</ArticleId></ArticleIdList></Reference><Reference><Citation>Selbert S, Fischer P, Menke A, et al. Annexin VII relocalization as a result of dystrophin deficiency. Exp Cell Res 1996;222:199-208. 10.1006/excr.1996.0025</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1996.0025</ArticleId><ArticleId IdType="pubmed">8549664</ArticleId></ArticleIdList></Reference><Reference><Citation>Herr C, Clemen CS, Lehnert G, et al. Function, expression and localization of annexin A7 in platelets and red blood cells: insights derived from an annexin A7 mutant mouse. BMC Biochem 2003;4:8. 10.1186/1471-2091-4-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2091-4-8</ArticleId><ArticleId IdType="pmc">PMC194730</ArticleId><ArticleId IdType="pubmed">12925238</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal T, Rentero C, Enrich C, et al. Annexin Animal Models-From Fundamental Principles to Translational Research. Int J Mol Sci 2021;22:3439. 10.3390/ijms22073439</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073439</ArticleId><ArticleId IdType="pmc">PMC8037771</ArticleId><ArticleId IdType="pubmed">33810523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas E, Pollard HB. Membrane capacity measurements suggest a calcium-dependent insertion of synexin into phosphatidylserine bilayers. FEBS Lett 1987;217:25-31. 10.1016/0014-5793(87)81235-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(87)81235-8</ArticleId><ArticleId IdType="pubmed">2954851</ArticleId></ArticleIdList></Reference><Reference><Citation>Caohuy H, Srivastava M, Pollard HB. Membrane fusion protein synexin (annexin VII) as a Ca2+/GTP sensor in exocytotic secretion. Proc Natl Acad Sci U S A 1996;93:10797-802. 10.1073/pnas.93.20.10797</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.20.10797</ArticleId><ArticleId IdType="pmc">PMC38235</ArticleId><ArticleId IdType="pubmed">8855260</ArticleId></ArticleIdList></Reference><Reference><Citation>Creutz CE, Sterner DC. Calcium dependence of the binding of synexin to isolated chromaffin granules. Biochem Biophys Res Commun 1983;114:355-64. 10.1016/0006-291X(83)91635-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(83)91635-2</ArticleId><ArticleId IdType="pubmed">6224488</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;ring V, Veretout F, Albrecht R, et al. The in vivo role of annexin VII (synexin): characterization of an annexin VII-deficient Dictyostelium mutant indicates an involvement in Ca(2+)-regulated processes. J Cell Sci 1995;108 (Pt 5):2065-76. 10.1242/jcs.108.5.2065</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.108.5.2065</ArticleId><ArticleId IdType="pubmed">7657724</ArticleId></ArticleIdList></Reference><Reference><Citation>Monastyrskaya K, Tschumi F, Babiychuk EB, et al. Annexins sense changes in intracellular pH during hypoxia. Biochem J 2008;409:65-75. 10.1042/BJ20071116</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20071116</ArticleId><ArticleId IdType="pubmed">17824845</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijpers GA, Lee G, Pollard HB. Immunolocalization of synexin (annexin VII) in adrenal chromaffin granules and chromaffin cells: evidence for a dynamic role in the secretory process. Cell Tissue Res 1992;269:323-30. 10.1007/BF00319624</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00319624</ArticleId><ArticleId IdType="pubmed">1423500</ArticleId></ArticleIdList></Reference><Reference><Citation>Monastyrskaya K, Babiychuk EB, Draeger A. The annexins: spatial and temporal coordination of signaling events during cellular stress. Cell Mol Life Sci 2009;66:2623-42. 10.1007/s00018-009-0027-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-009-0027-1</ArticleId><ArticleId IdType="pmc">PMC11115530</ArticleId><ArticleId IdType="pubmed">19381436</ArticleId></ArticleIdList></Reference><Reference><Citation>Selbert S, Fischer P, Pongratz D, et al. Expression and localization of annexin VII (synexin) in muscle cells. J Cell Sci 1995;108 (Pt 1):85-95. 10.1242/jcs.108.1.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.108.1.85</ArticleId><ArticleId IdType="pubmed">7738119</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemen CS, Herr C, Lie AA, et al. Annexin VII: an astroglial protein exhibiting a Ca2+-dependent subcellular distribution. Neuroreport 2001;12:1139-44. 10.1097/00001756-200105080-00018</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200105080-00018</ArticleId><ArticleId IdType="pubmed">11338180</ArticleId></ArticleIdList></Reference><Reference><Citation>Caohuy H, Pollard HB. Activation of annexin 7 by protein kinase C in vitro and in vivo. J Biol Chem 2001;276:12813-21. 10.1074/jbc.M008482200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M008482200</ArticleId><ArticleId IdType="pubmed">11278415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Su L, Zhang S, et al. Inhibition of ANXA7 GTPase activity by a small molecule promotes HMBOX1 translation of vascular endothelial cells in vitro and in vivo. Int J Biochem Cell Biol 2016;79:33-40. 10.1016/j.biocel.2016.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2016.08.010</ArticleId><ArticleId IdType="pubmed">27506770</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Lin Z, Ning J, et al. Promoting TTC4 and HSP70 interaction and translocation of annexin A7 to lysosome inhibits apoptosis in vascular endothelial cells. FASEB J 2020;34:12932-45. 10.1096/fj.202000067R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000067R</ArticleId><ArticleId IdType="pubmed">33000523</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Liu N, Wang S, et al. Identification of a small molecule targeting annexin A7. Biochim Biophys Acta 2013;1833:2092-9. 10.1016/j.bbamcr.2013.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.04.015</ArticleId><ArticleId IdType="pubmed">23651924</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-81. 10.1152/physrev.00024.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00024.2005</ArticleId><ArticleId IdType="pubmed">16601268</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan R, Liu N, Yan Y, et al. Apoptosis, autophagy and atherosclerosis: Relationships and the role of Hsp27. Pharmacol Res 2021;166:105169. 10.1016/j.phrs.2020.105169</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105169</ArticleId><ArticleId IdType="pubmed">33053445</ArticleId></ArticleIdList></Reference><Reference><Citation>Torisu K, Singh KK, Torisu T, et al. Intact endothelial autophagy is required to maintain vascular lipid homeostasis. Aging Cell 2016;15:187-91. 10.1111/acel.12423</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12423</ArticleId><ArticleId IdType="pmc">PMC4717267</ArticleId><ArticleId IdType="pubmed">26780888</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao JY, Kaji K, Hayashi H, et al. Suppression of apoptosis by inhibition of phosphatidylcholine-specific phospholipase C in vascular endothelial cells. Endothelium 1997;5:231-9. 10.3109/10623329709052588</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10623329709052588</ArticleId><ArticleId IdType="pubmed">9588815</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Zhao Q, Liu X, et al. Phosphatidylcholine-specific phospholipase C, p53 and ROS in the association of apoptosis and senescence in vascular endothelial cells. FEBS Lett 2006;580:4911-5. 10.1016/j.febslet.2006.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.08.008</ArticleId><ArticleId IdType="pubmed">16920112</ArticleId></ArticleIdList></Reference><Reference><Citation>Eurtivong C, Leung E, Sharma N, et al. Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target. Molecules 2023;28:5637. 10.3390/molecules28155637</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28155637</ArticleId><ArticleId IdType="pmc">PMC10420013</ArticleId><ArticleId IdType="pubmed">37570610</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Huang S, Wang S, et al. 
Targeting annexin A7 by a small molecule suppressed the activity of phosphatidylcholine-specific phospholipase C in vascular endothelial cells and inhibited atherosclerosis in apolipoprotein E<sup>&#x2212;</sup>/<sup>&#x2212;</sup>mice.
Cell Death Dis
2013;4:e806. 10.1038/cddis.2013.317
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.317</ArticleId><ArticleId IdType="pmc">PMC3789175</ArticleId><ArticleId IdType="pubmed">24052074</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Dong Z, Huang B, et al. Distinct patterns of autophagy evoked by two benzoxazine derivatives in vascular endothelial cells. Autophagy 2010;6:1115-24. 10.4161/auto.6.8.13508</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.8.13508</ArticleId><ArticleId IdType="pubmed">20890130</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Lu W, Ge D, et al. A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells. Autophagy 2015;11:2172-83. 10.1080/15548627.2015.1106663</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1106663</ArticleId><ArticleId IdType="pmc">PMC4835209</ArticleId><ArticleId IdType="pubmed">26565952</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Zhao X, Su L, et al. MROH7-TTC4 read-through lncRNA suppresses vascular endothelial cell apoptosis and is upregulated by inhibition of ANXA7 GTPase activity. FEBS J 2019;286:4937-50. 10.1111/febs.15038</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15038</ArticleId><ArticleId IdType="pubmed">31408583</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Liu N, Li H, et al. TIA1 interacts with annexin A7 in regulating vascular endothelial cell autophagy. Int J Biochem Cell Biol 2014;57:115-22. 10.1016/j.biocel.2014.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2014.10.015</ArticleId><ArticleId IdType="pubmed">25461769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Devalaraja M, Baeres FMM, et al. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 2021;397:2060-9. 10.1016/S0140-6736(21)00520-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00520-1</ArticleId><ArticleId IdType="pubmed">34015342</ArticleId></ArticleIdList></Reference><Reference><Citation>Miceli G, Basso MG, Rizzo G, et al. The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies. Int J Mol Sci 2022;23:14914. 10.3390/ijms232314914</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314914</ArticleId><ArticleId IdType="pmc">PMC9739112</ArticleId><ArticleId IdType="pubmed">36499242</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med 2019;381:2497-505. 10.1056/NEJMoa1912388</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1912388</ArticleId><ArticleId IdType="pubmed">31733140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CC, Hsieh HL, Chi PL, et al. Upregulation of COX-2/PGE2 by ET-1 mediated through Ca2+-dependent signals in mouse brain microvascular endothelial cells. Mol Neurobiol 2014;49:1256-69. 10.1007/s12035-013-8597-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8597-1</ArticleId><ArticleId IdType="pubmed">24287977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM. Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis. Circ Res 2019;124:437-50. 10.1161/CIRCRESAHA.118.313129</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313129</ArticleId><ArticleId IdType="pmc">PMC6386195</ArticleId><ArticleId IdType="pubmed">30702995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017;377:1119-31. 10.1056/NEJMoa1707914</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1707914</ArticleId><ArticleId IdType="pubmed">28845751</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Lin J, Hu T, et al. Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin &#x3b2;1-RhoA-JNK signaling activation. J Cell Physiol 2019;234:10990-1000. 10.1002/jcp.27910</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27910</ArticleId><ArticleId IdType="pmc">PMC6590151</ArticleId><ArticleId IdType="pubmed">30536538</ArticleId></ArticleIdList></Reference><Reference><Citation>DeRoo EP, Wrobleski SK, Shea EM, et al. The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood 2015;125:1813-21. 10.1182/blood-2014-04-569939</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-04-569939</ArticleId><ArticleId IdType="pmc">PMC4357586</ArticleId><ArticleId IdType="pubmed">25428218</ArticleId></ArticleIdList></Reference><Reference><Citation>Knall C, Young S, Nick JA, et al. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem 1996;271:2832-8. 10.1074/jbc.271.5.2832</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.5.2832</ArticleId><ArticleId IdType="pubmed">8576262</ArticleId></ArticleIdList></Reference><Reference><Citation>Taub DD, Anver M, Oppenheim JJ, et al. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest 1996;97:1931-41. 10.1172/JCI118625</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118625</ArticleId><ArticleId IdType="pmc">PMC507263</ArticleId><ArticleId IdType="pubmed">8621778</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhao J, Su L, et al. D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis. Arterioscler Thromb Vasc Biol 2010;30:411-8. 10.1161/ATVBAHA.109.195768</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.109.195768</ArticleId><ArticleId IdType="pubmed">20139365</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Li H, Wang Z, et al. Evidence for the role of phosphatidylcholine-specific phospholipase in experimental subarachnoid hemorrhage in rats. Exp Neurol 2015;272:145-51. 10.1016/j.expneurol.2015.02.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.02.031</ArticleId><ArticleId IdType="pubmed">25743218</ArticleId></ArticleIdList></Reference><Reference><Citation>Mears D, Zimliki CL, Atwater I, et al. The Anx7(+/-) knockout mutation alters electrical and secretory responses to Ca(2+)-mobilizing agents in pancreatic &#x3b2;-cells. Cell Physiol Biochem 2012;29:697-704. 10.1159/000186926</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000186926</ArticleId><ArticleId IdType="pubmed">22613970</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2014;20:1126-67. 10.1089/ars.2012.5149</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.5149</ArticleId><ArticleId IdType="pmc">PMC3929010</ArticleId><ArticleId IdType="pubmed">23991888</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosmas CE, Silverio D, Sourlas A, et al. Anti-inflammatory therapy for cardiovascular disease. Ann Transl Med 2019;7:147. 10.21037/atm.2019.02.34</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2019.02.34</ArticleId><ArticleId IdType="pmc">PMC6511577</ArticleId><ArticleId IdType="pubmed">31157268</ArticleId></ArticleIdList></Reference><Reference><Citation>Miceli G, Basso MG, Pintus C, et al. Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review. Int J Mol Sci 2024;25:4351. 10.3390/ijms25084351</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25084351</ArticleId><ArticleId IdType="pmc">PMC11050267</ArticleId><ArticleId IdType="pubmed">38673936</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe N, Ikeda U. Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 2004;6:112-20. 10.1007/s11883-004-0099-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-004-0099-1</ArticleId><ArticleId IdType="pubmed">15023295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellulu MS, Patimah I, Khaza'ai H, et al. Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacology 2016;24:1-10. 10.1007/s10787-015-0255-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-015-0255-y</ArticleId><ArticleId IdType="pubmed">26750181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ib&#xe1;&#xf1;ez B, Heusch G, Ovize M, et al. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 2015;65:1454-71. 10.1016/j.jacc.2015.02.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.02.032</ArticleId><ArticleId IdType="pubmed">25857912</ArticleId></ArticleIdList></Reference><Reference><Citation>Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 2017;38:774-84.</Citation><ArticleIdList><ArticleId IdType="pubmed">27354052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Wu J, Yang Z, et al. Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications. Cell Biol Toxicol 2023;39:33-51. 10.1007/s10565-022-09716-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10565-022-09716-2</ArticleId><ArticleId IdType="pubmed">35951200</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings RB, Hawkins HK, Lowe JE, et al. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol 1978;92:187-214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2018580</ArticleId><ArticleId IdType="pubmed">686146</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med 2011;17:1391-401. 10.1038/nm.2507</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2507</ArticleId><ArticleId IdType="pmc">PMC3886192</ArticleId><ArticleId IdType="pubmed">22064429</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Camara AK, Stowe DF, et al. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol 2007;292:C137-47. 10.1152/ajpcell.00270.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00270.2006</ArticleId><ArticleId IdType="pubmed">16971498</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesnefsky EJ, Chen Q, Tandler B, et al. Mitochondrial Dysfunction and Myocardial Ischemia-Reperfusion: Implications for Novel Therapies. Annu Rev Pharmacol Toxicol 2017;57:535-65. 10.1146/annurev-pharmtox-010715-103335</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010715-103335</ArticleId><ArticleId IdType="pmc">PMC11060135</ArticleId><ArticleId IdType="pubmed">27860548</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng K, Lu S, Yan X, et al. Quantitative Mitochondrial Proteomics Reveals ANXA7 as a Crucial Factor in Mitophagy. J Proteome Res 2020;19:1275-84. 10.1021/acs.jproteome.9b00800</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.9b00800</ArticleId><ArticleId IdType="pubmed">31975592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubli DA, Gustafsson &#xc5;B. Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 2012;111:1208-21. 10.1161/CIRCRESAHA.112.265819</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.112.265819</ArticleId><ArticleId IdType="pmc">PMC3538875</ArticleId><ArticleId IdType="pubmed">23065344</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao CM, Yan WY, Liu J, et al. Attenuation of mitochondrial, but not cytosolic, Ca2+ overload reduces myocardial injury induced by ischemia and reperfusion. Acta Pharmacol Sin 2006;27:911-8. 10.1111/j.1745-7254.2006.00391.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7254.2006.00391.x</ArticleId><ArticleId IdType="pubmed">16787576</ArticleId></ArticleIdList></Reference><Reference><Citation>Negri S, Faris P, Moccia F. Reactive Oxygen Species and Endothelial Ca(2+) Signaling: Brothers in Arms or Partners in Crime? Int J Mol Sci 2021;22:9821. 10.3390/ijms22189821</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22189821</ArticleId><ArticleId IdType="pmc">PMC8465413</ArticleId><ArticleId IdType="pubmed">34575985</ArticleId></ArticleIdList></Reference><Reference><Citation>Camors E, Monceau V, Charlemagne D. Annexins and Ca2+ handling in the heart. Cardiovasc Res 2005;65:793-802. 10.1016/j.cardiores.2004.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2004.11.010</ArticleId><ArticleId IdType="pubmed">15721859</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarrese P, Tinari N, Semeraro ML, et al. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 2000;473:311-5. 10.1016/S0014-5793(00)01547-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(00)01547-7</ArticleId><ArticleId IdType="pubmed">10818231</ArticleId></ArticleIdList></Reference><Reference><Citation>Amberger A, Weiss H, Haller T, et al. A subpopulation of mitochondria prevents cytosolic calcium overload in endothelial cells after cold ischemia/reperfusion. Transplantation 2001;71:1821-7. 10.1097/00007890-200106270-00019</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007890-200106270-00019</ArticleId><ArticleId IdType="pubmed">11455264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Finley RL, Jr, Raz A, et al. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 2002;277:15819-27. 10.1074/jbc.M200154200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200154200</ArticleId><ArticleId IdType="pubmed">11839755</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SP, Schoenwaelder SM. Antiplatelet therapy: in search of the 'magic bullet'. Nat Rev Drug Discov 2003;2:775-89. 10.1038/nrd1198</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1198</ArticleId><ArticleId IdType="pubmed">14526381</ArticleId></ArticleIdList></Reference><Reference><Citation>Castrichini M, Luzum JA, Pereira N. Pharmacogenetics of Antiplatelet Therapy. Annu Rev Pharmacol Toxicol 2023;63:211-29. 10.1146/annurev-pharmtox-051921-092701</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-051921-092701</ArticleId><ArticleId IdType="pmc">PMC9868113</ArticleId><ArticleId IdType="pubmed">35914768</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrono C, Rocca B. Aspirin, 110 years later. J Thromb Haemost 2009;7 Suppl 1:258-61. 10.1111/j.1538-7836.2009.03391.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2009.03391.x</ArticleId><ArticleId IdType="pubmed">19630812</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung J, Apopa PL, Vesci J, et al. 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity. Thromb Haemost 2013;110:569-81. 10.1160/TH13-01-0014</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH13-01-0014</ArticleId><ArticleId IdType="pmc">PMC3960303</ArticleId><ArticleId IdType="pubmed">23784669</ArticleId></ArticleIdList></Reference><Reference><Citation>Santilli F, Rocca B, De Cristofaro R, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol 2009;53:667-77. 10.1016/j.jacc.2008.10.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.10.047</ArticleId><ArticleId IdType="pubmed">19232899</ArticleId></ArticleIdList></Reference><Reference><Citation>Maskrey BH, Rushworth GF, Law MH, et al. 12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition. J Inflamm (Lond) 2014;11:33. 10.1186/s12950-014-0033-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-014-0033-4</ArticleId><ArticleId IdType="pmc">PMC4209229</ArticleId><ArticleId IdType="pubmed">25349537</ArticleId></ArticleIdList></Reference><Reference><Citation>Holinstat M. Controlling the Clot: ANXA7 Regulates Collagen Activation of Platelet Through 12-LOX. Circ Res 2021;129:508-10. 10.1161/CIRCRESAHA.121.319736</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319736</ArticleId><ArticleId IdType="pubmed">34351797</ArticleId></ArticleIdList></Reference><Reference><Citation>Meers P, Bentz J, Alford D, et al. Synexin enhances the aggregation rate but not the fusion rate of liposomes. Biochemistry 1988;27:4430-9. 10.1021/bi00412a033</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00412a033</ArticleId><ArticleId IdType="pubmed">2971392</ArticleId></ArticleIdList></Reference><Reference><Citation>Meers P, Hong K, Papahadjopoulos D. Free fatty acid enhancement of cation-induced fusion of liposomes: synergism with synexin and other promoters of vesicle aggregation. Biochemistry 1988;27:6784-94. 10.1021/bi00418a021</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00418a021</ArticleId><ArticleId IdType="pubmed">2973806</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeland IJ, Ross R, Despr&#xe9;s JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 2019;7:715-25. 10.1016/S2213-8587(19)30084-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(19)30084-1</ArticleId><ArticleId IdType="pubmed">31301983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourdot BE, Holinstat M. Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy. Trends Pharmacol Sci 2017;38:1006-15. 10.1016/j.tips.2017.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2017.08.001</ArticleId><ArticleId IdType="pubmed">28863985</ArticleId></ArticleIdList></Reference><Reference><Citation>Adili R, Tourdot BE, Mast K, et al. First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis. Arterioscler Thromb Vasc Biol 2017;37:1828-39. 10.1161/ATVBAHA.117.309868</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.117.309868</ArticleId><ArticleId IdType="pmc">PMC5620123</ArticleId><ArticleId IdType="pubmed">28775075</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung J, Tourdot BE, Fernandez-Perez P, et al. Platelet 12-LOX is essential for Fc&#x3b3;RIIa-mediated platelet activation. Blood 2014;124:2271-9. 10.1182/blood-2014-05-575878</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-05-575878</ArticleId><ArticleId IdType="pmc">PMC4183986</ArticleId><ArticleId IdType="pubmed">25100742</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung J, Apopa PL, Vesci J, et al. Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation. Mol Pharmacol 2012;81:420-30. 10.1124/mol.111.075630</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.111.075630</ArticleId><ArticleId IdType="pmc">PMC3286293</ArticleId><ArticleId IdType="pubmed">22155783</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh A, Ikeda H, Murohara T, et al. Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation. Circulation 1998;98:2891-8. 10.1161/01.CIR.98.25.2891</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.98.25.2891</ArticleId><ArticleId IdType="pubmed">9860792</ArticleId></ArticleIdList></Reference><Reference><Citation>Poch E. Role of lipoxygenase metabolites in cardiovascular disease. Curr Hypertens Rep 2003;5:1-2. 10.1007/s11906-003-0001-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-003-0001-5</ArticleId><ArticleId IdType="pubmed">12530928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Gao L, Xiao L, et al. 12(S)-hydroxyeicosatetraenoic acid impairs vascular endothelial permeability by altering adherens junction phosphorylation levels and affecting the binding and dissociation of its components in high glucose-induced vascular injury. J Diabetes Investig 2019;10:639-49. 10.1111/jdi.12941</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdi.12941</ArticleId><ArticleId IdType="pmc">PMC6497583</ArticleId><ArticleId IdType="pubmed">30251333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikei KN, Yeung J, Apopa PL, et al. Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation. J Lipid Res 2012;53:2546-59. 10.1194/jlr.M026385</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M026385</ArticleId><ArticleId IdType="pmc">PMC3494251</ArticleId><ArticleId IdType="pubmed">22984144</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Boeglin WE, Brash AR. Analysis of 12/15-lipoxygenase metabolism of EPA and DHA with special attention to authentication of docosatrienes. J Lipid Res 2021;62:100088. 10.1016/j.jlr.2021.100088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jlr.2021.100088</ArticleId><ArticleId IdType="pmc">PMC8219989</ArticleId><ArticleId IdType="pubmed">34022182</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi A, Stanger L, Freedman CJ, et al. DHA 12-LOX-derived oxylipins regulate platelet activation and thrombus formation through a PKA-dependent signaling pathway. J Thromb Haemost 2021;19:839-51. 10.1111/jth.15184</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15184</ArticleId><ArticleId IdType="pmc">PMC7925359</ArticleId><ArticleId IdType="pubmed">33222370</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis E, Moysidis DV, Papazoglou AS, et al. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease. Cardiovasc Diabetol 2022;21:70. 10.1186/s12933-022-01494-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01494-9</ArticleId><ArticleId IdType="pmc">PMC9077877</ArticleId><ArticleId IdType="pubmed">35525960</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha D, New G, Collins P, et al. Radial artery pulse wave analysis for non-invasive assessment of coronary artery disease. Int J Cardiol 2013;167:917-24. 10.1016/j.ijcard.2012.03.098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.03.098</ArticleId><ArticleId IdType="pubmed">22483418</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinson P, Gaze D, Goodacre S. Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain. Heart 2014;100:140-5. 10.1136/heartjnl-2013-304716</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2013-304716</ArticleId><ArticleId IdType="pubmed">24270743</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LH, van Borren M, Gemen E, et al. Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin. Ann Clin Biochem 2015;52:550-61. 10.1177/0004563215578189</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004563215578189</ArticleId><ArticleId IdType="pubmed">25732130</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YZ, Wang YY, Huang L, et al. Annexin A protein family in atherosclerosis. Clin Chim Acta 2022;531:406-17. 10.1016/j.cca.2022.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2022.05.009</ArticleId><ArticleId IdType="pubmed">35562096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YY, Xu Y, Yang KC, et al. Prognostic significance of serum annexin A7 in severe traumatic brain injury: A prospective longitudinal cohort study. Clin Chim Acta 2022;535:46-52. 10.1016/j.cca.2022.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2022.08.010</ArticleId><ArticleId IdType="pubmed">35985500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Yuegao, Bai L, et al. Evaluation of Annexin A7, Galectin-3 and Gelsolin as possible biomarkers of hepatocarcinoma lymphatic metastasis. Biomed Pharmacother 2014;68:259-65. 10.1016/j.biopha.2013.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2013.12.009</ArticleId><ArticleId IdType="pubmed">24529848</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>